New drugs for reducing cardiovascular risk in women
Diabetes and hyperlipidemia
Holly L. Thacker, MD, FACP
Associate Director, Menopause Center; Head, Section of Women's Health; Staff, General Internal Medicine and Gynecology and Obstetrics departments, Cleveland Clinic; and Assistant Professor of Internal Medicine, Ohio State University
Hussein Saadi, MD
Staff, General Internal Medicine and Endocrinology departments, Cleveland Clinic. Dr. Saadi's major interests are thyroid and lipid disorders and diabetes.
Address: Holly L. Thacker, MD, FACP, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195
ABSTRACT
Atherosclerosis is largely preventable in women. Clinicians need to appreciate the gender-associated risks of cardiovascular disease and emphasize to their women patients that life-style changes can reduce cardiovascular risk. However, newer oral agents for diabetes and the statins for hyperlipidemia are important pharmacological adjuncts.